2023 Future of Health Data Summit Recap
On October 3, leaders from across healthcare gathered in Washington, D.C. to discuss emerging opportunities and challenges around the use of health data to improve patient outcomes.
To see e-Book of top takeaways, please fill out the form below.
“There is so much focus on the “digital divide,” I would call it the “data divide””
VP Global Head of Health Economics and Outcomes Research, Abbvie
“Healthcare is the only industry that doesn’t study its own gold standard, which is wellness.”
Nathan D. Price
Chief Scientific Officer, Thorne HealthTech
“Healthcare is a big data problem. There is enough data in the system to do predictive analysis, and have better patient outcomes, better cost structure for payers and providers, but we’re not optimizing any of that data.”
Corporate Vice President, Microsoft
“The access issues ARE the issues.”
CRIO and Associate Dean, College of Medicine, The Ohio State University
“The most patient centric thing you can do right now is create a longitudinal record.”
“I worry people want to leave the pandemic behind. Those lessons learned [on sharing data] only help if we build on them. What gives me hope is the solidifying convo around what we need to do to be more ready.”
Chief Medical Officer, FD
On Demand: Summit Replays
Datavant CEO Pete McCabe opened the 2023 Future of Health Data Summit discussing the biggest problem with health data today: a broken data supply chain.
Opening Keynote 2023
At The Future of Health Data Summit hosted by Datavant in September 2023 in Washington, D.C., Peter Slavin, Former President of Massachusetts General Hospital, called on industry leaders to take better care of the healthcare workforce. Dr. Slavin was joined by Pete McCabe, CEO of Datavant.
Unifying Healthcare Data: Next Generation Patient Registries
What makes for a useful patient registry? This panel discussed existing shortfalls in patient registries, what patient registries look like in 2023, and what patient registries might look like in an AI-driven future.
The Cost of Complexity: Navigating the Privacy “Hurricane”
As the healthcare industry works to accelerate patient access to their own health data, this panel discussed the challenges of building and maintaining trust, and the role of transparency in that process.
Fireside Chat: The Power of Prioritizing Health Equity and Access to Disrupt Clinical Trials
This conversation, between John Wig, Chief Medical Officer of Walmart and Tara Grabowsky, Partner and Chief Data Officer of Life Sciences Practice at McKinsey, discussed Walmart’s role in developing clinical trials, building patient registries, and cultivating healthcare access and affordability.
A Roadmap to Resilience: Are We Ready for the Next Pandemic Threat?
What lessons have we held onto from the COVID-19 pandemic? This panel explored how the public-private partnerships that were established during the pandemic affect our current data readiness, as well as how we can better navigate complex regulatory jurisdictions to maintain critical data flow in times of crisis.
The Analytics Advantage: Elevating Employee Wellbeing with Data
This panel at The Future of Health Data Summit discussed how employers can take a more data-driven approach to health plan management to positively impact employee health and well being.
Who Wants to Live to Be a 100 Years Old: How the Data World Can Help Us Live Longer
This panel explored challenges in understanding longevity in the US, and if AI could play a role in answering the complex questions involved in a holistic understanding of human longevity.
Fireside Chat: Last Mile Health – Shaping Healthcare Around the Patient
This conversation between Alice Chen, Chief Health Officer of Centene, Melanie Fontes Rainer, Director of the Office for Civil Rights, HHS, and R. Martin Chavez, Partner and Vice Chairman for Sixth Street Partners centered around health equity and how we can better design the healthcare system to work for all patients.
AI: Opportunities, Risks and Regulations in A New Era
AI has the potential to touch all parts of the healthcare industry. While still in its infancy, this panel imagined scenarios for how and where to deploy AI in order to maximize its potential for improving patient outcomes.
Curbing the Cost Crisis: The Digital Prescription for Affordable Clinical Trials
Large fit-for-purpose clinical trials remain prohibitively expensive and challenging to organize. This panel discussed building patient trust and finding alternative routes to organizing large clinical trials.
The Digital Landscape for Mental Health: Using Technology to Drive Outcomes
The data tells us that mental health practitioners lag behind other healthcare providers in their incorporation of patient data into their practice. This panel discussed successful data interventions within the mental health ecosystem and how these could be expanded upon to improve mental health practice and patient access.
The Critical Path to Connected Health Systems: Where Do We Go From Here?
Progress toward digitizing all health records has been substantial since the passages of HIPAA and the ACA. How is TEFCA transforming digital access to health records, and what blockers still remain? This panel discussed the long road toward fully digital health records and the experience of a “single health data network.”
Fireside Chat: Regulating the Future – FDA’s Role in Powering Innovation from Bench to Bedside
This conversation between Robert Califf, Commissioner of the FDA and Datavant’s Chief Scientific Officer, Vera Mucaj discussed the current climate around regulation and regulatory bodies, as well as some of the challenges of regulating the rapidly accelerating AI sector.
The Future of Health Data Summit: Key Learnings from Datavant’s Gathering of Leaders from Across the Healthcare Ecosystem
Chief Executive Officer, Datavant